Below are the best resources we could find featuring monnica williams about psychedelic assisted therapy.
CLEAR ALL
“Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy” Monnica Williams, Ph.D.
In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.
1
In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
2
Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.
Monnica T. Williams, Ph.D., ABPP, is an Associate Professor in the School of Psychology at the University of Ottawa, Canada Research Chair in Mental Health Disparities, and Director of the Laboratory for Culture and Mental Health Disparities.
Dr. Monnica T. Williams discusses her work in assessing racial trauma and mental health disparities in African-American communities.
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.